Hjem › Vaso-okklusive kriser
Vaso-okklusive kriser kliniske forsøg rekrutterer i USA
7 studier for Vaso-okklusive kriser rekrutterer deltagere på steder over hele USA.
Byer med flest studier
Efter delstat
Nyligt opdaterede studier
Officiel studietekst (engelsk)
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
RekruttererFase 3
Alder 12 til 100 · Alle køn · Opdateret 28. sep. 2026 · NCT06439082Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults
RekruttererFase 2
Alder 5 til 20 · Alle køn · Opdateret 2. sep. 2026 · NCT07369024Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
RekruttererFase 2
Alder 12 og opefter · Alle køn · Opdateret 14. aug. 2026 · NCT06699849Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 5. aug. 2026 · NCT07224360Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
RekruttererFase 4
6 Months – 100 Years · Alle køn · Opdateret 8. jun. 2026 · NCT04657822Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
Rekrutterer
Alder 6 til 25 · Alle køn · Opdateret 18. maj 2026 · NCT03353584Sickle Cell Improvement: Enhancing Care in the Emergency Department
Rekrutterer
Op til 18 år · Alle køn · Opdateret 14. aug. 2023 · NCT05373771Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.